Avanos Medical, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AVNS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

203,257

Value ($000)

2,283

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,283	0.0%	203,257	12/31/2025
2025 Q3	11/14/2025	2,489	0.0%	215,344	9/30/2025
2025 Q2	8/14/2025	3,408	0.0%	278,466	6/30/2025
2025 Q1	5/19/2025	2,018	0.0%	140,810	3/31/2025
2024 Q4	2/14/2025	1,915	0.0%	120,269	12/31/2024
2024 Q3	11/14/2024	2,607	0.0%	108,470	9/30/2024
2024 Q2	8/14/2024	1,929	0.0%	96,857	6/30/2024
2024 Q1	5/15/2024	1,228	0.0%	61,687	3/31/2024
2023 Q4	2/14/2024	1,384	0.0%	61,687	12/31/2023
2023 Q3	11/13/2023	1,166	0.0%	57,669	9/30/2023
2023 Q2	8/11/2023	1,718	0.0%	57,766	6/30/2023
2023 Q1	5/15/2023	1,718	0.0%	57,766	3/31/2023
2022 Q4	2/14/2023	1,278	0.0%	47,224	12/31/2022
2022 Q3	11/14/2022	899	0.0%	41,271	9/30/2022
2022 Q2	8/12/2022	1,241	0.0%	45,406	6/30/2022
2022 Q1	5/16/2022	1,521	0.0%	45,406	3/31/2022
2021 Q4	2/14/2022	1,432	0.0%	41,303	12/31/2021
2021 Q3	11/15/2021	1,330	0.0%	42,614	9/30/2021
2021 Q2	8/16/2021	1,744	0.0%	47,952	6/30/2021
2021 Q1	5/14/2021	2,057	0.0%	47,029	3/31/2021
2020 Q4	3/1/2021	2,127	0.0%	46,360	12/31/2020
2020 Q3	11/13/2020	1,796	0.0%	54,054	9/30/2020
2020 Q2	8/14/2020	1,393	0.0%	47,382	6/30/2020
2020 Q1	5/15/2020	1,399	0.0%	51,941	3/31/2020
2019 Q4	2/14/2020	1,581	0.0%	46,906	12/31/2019